Do you want to read an article? Please log in or register.
Association of proton pump inhibitor use with outcome of patients with recurrent glioblastoma
Central Nervous System Tumors
Related content
Further Publications
The association between metformin use, immune mediated colitis and overall survival in patients treated with checkpoint inhibitor
Eur J Cancer
Shatila M, Cruz CC, Lu L, Abdul-Baki K, Baerman E, Takigawa K, Rivera AU, Lee IJ, Ngo S, Sperling G, Aleem AS, Menon R, Sullivan A, Vemulapalli V, Natha C, Gupta T, Khan A, Mittal N, Coleman G, Salim H, Wali S, Varatharajalu K, Kim KC, Reddy SA, Grivas P, Thomas AS, Wang Y
doi: 10.1016/j.ejca.2025.115405
COMMENTED
Genitourinary Cancer
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
Eur Urol
Freedland SJ, Mulhall JP, Gleave M, Giorgi U, Saad F, Rannikko A, Ivanova JI, Nasr AF, Reisman AL, Ganguli A, Kral P, Turnbull J, Shore N
doi: 10.1016/j.eururo.2025.02.006
Breast Cancer
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy
Ann Oncol
Mayer EL, Bidard FC, Park YH, Janni W, Ma C, Cristofanilli M, Iwata H, Bianchini G, Kalinsky K, Chia S, Brufsky A, Fasching PA, Nowecki Z, Chen SC, Pascual J, Moreau L, Ruiz-Borrego M, Shai A, Karadurmus N, Sohn JH, Zhu Y, Leddin I, Miralles MS, Bartlett CH, Turner N
doi: 10.1016/j.annonc.2025.10.006
Breast Cancer
Cardiovascular Adverse Events and Associated Costs of CDK4/6 Inhibitors in Patients With Breast Cancer
J Natl Compr Canc Netw
Park C, Liu YS, Kenawy AS, Lin YH, Liu Y, Heo JH
doi: 10.6004/jnccn.2025.7001
Lung, Respiratory and Thoracic Cancer
Safety and outcomes of intensity modulated proton therapy in patients with non small cell lung cancer with interstitial lung disease
Lung Cancer
Roden RT, Harmsen WS, Breen WG, Moffett JN, Pulsipher SD, Olivier KR, Garces YI, Park SS, Merrell KW, Sarkaria JN, Owen D
doi: 10.1016/j.lungcan.2025.108789
Genitourinary Cancer
Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Clin Cancer Res
Hage Chehade C, Graf RP, Ozay ZI, Gebrael G, Sayegh N, Li G, Maughan BL, Antonarakis ES, McKay RR, Agarwal N, Swami U
doi: 10.1158/1078-0432.CCR-25-1178
Gynecologic Cancer
Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy
J Gynecol Oncol
Bartl T, Dorittke T, Ciocsirescu C, Knoth J, Schmid M, Grimm C, Sturdza A
doi: 10.3802/jgo.2025.36.e99
CHICAGO 2025
Genitourinary Cancer
Earlier initiation of 177Lu-PSMA-617 is associated with improved clinical outcomes in patients with mCRPC in a real-world setting
Lung, Respiratory and Thoracic Cancer
Pretreatment eosinophilia as a biomarker for adverse outcomes in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis
Semin Oncol
Ganatra N, Thompson J, Desai R, Doshi J, Jain P, Pasnoor DS, Jain A
doi: 10.1016/j.seminoncol.2025.152431